
| Key Data | |
|---|---|
| Drug (brand/generic) | Exubera |
| Company/licensee | Aventis and Pfizer |
| Therapy class | Rapid-acting insulin |
| Product description | Inhaled insulin preparation |
| Current indication | Insulin-treated diabetes |
| Market sector | Diabetes |
| Development status | Product withdrawn in October 2007 |
